- Report
- January 2024
- 200 Pages
Global
From €4055EUR$4,150USD£3,385GBP
- Report
- June 2024
- 144 Pages
Global
From €3244EUR$3,320USD£2,708GBP
€4055EUR$4,150USD£3,385GBP
- Report
- November 2024
- 84 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- January 2024
- 178 Pages
Global
€4880EUR$4,995USD£4,074GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- July 2024
- 72 Pages
North America
From €2428EUR$2,485USD£2,027GBP
€3469EUR$3,550USD£2,896GBP
- Report
- July 2024
- 70 Pages
Africa, Middle East
From €2428EUR$2,485USD£2,027GBP
€3469EUR$3,550USD£2,896GBP
- Report
- July 2024
- 78 Pages
Europe
From €2428EUR$2,485USD£2,027GBP
€3469EUR$3,550USD£2,896GBP
- Report
- July 2024
- 78 Pages
Asia Pacific
From €2428EUR$2,485USD£2,027GBP
€3469EUR$3,550USD£2,896GBP
- Report
- January 2024
- 109 Pages
United States
€3420EUR$3,500USD£2,855GBP
- Report
- November 2024
Global
From €300EUR$329USD£259GBP
- Report
- April 2020
- 233 Pages
Global
From €3420EUR$3,500USD£2,855GBP
- Report
- July 2018
- 27 Pages
Global
From €9771EUR$10,000USD£8,157GBP
- Report
- July 2018
- 41 Pages
Global
From €9771EUR$10,000USD£8,157GBP
- Report
- February 2018
- 16 Pages
Global
From €9771EUR$10,000USD£8,157GBP
- Drug Pipelines
- February 2018
- 16 Pages
Global
From €9771EUR$10,000USD£8,157GBP
- Report
- February 2018
- 680 Pages
Global
From €21495EUR$22,000USD£17,945GBP
The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more